First canine ehrlichiosis vaccine developed in Israel

01/2/2013 | Israel21c

Veterinary researchers in Israel have developed the first ever vaccine for canine monocytic ehrlichiosis, a potentially deadly tick-borne disease that affects dogs. Although more research is needed to ensure the vaccine protects against other strains, a commercial vaccine will likely be developed.

View Full Article in:

Israel21c

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID